PF-Atlas › Clinical Trials › NCT00234663
PTC124 for Cystic Fibrosis
PTC124 · Phase 2
Registry ID
NCT00234663
Phase
Phase 2
Status
Completed
Drug / intervention
PTC124
Sponsor
PTC Therapeutics
Start
2005-09
About this trial
PTC124 is evaluated in NCT00234663, a Phase 2 idiopathic pulmonary fibrosis study sponsored by PTC Therapeutics. Current status: Completed.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT00234663 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.